HCDIP - MFGP API and AQST among pre market gainers

May, 03 2022 08:31 AM Harbor Custom Development Inc. 8.0% Series A Cumulative Convertible Preferred Stock no par value

Sonoma Pharmaceuticals SNOA +47% on EPA approval of Nanocyn as hospital-grade disinfectant. Field Trip Health (FTRP) +23%. Harbor Custom Development (HCDI) +18%. Western Digital WDC +12% as activist Elliott calls for separation of flash business. AST SpaceMobile ASTS +13% on FCC license to test direct-to-phone satellite. Micro Focus International (MFGP) +9%. KULR Technology (KULR) +8% provides biosensing solution for the metaverse. Blackboxstocks (BLBX) +8%. ALJ Regional Holdings (ALJJ) +7%. Borr Drilling (BORR) +7%. Harbor Custom Development (HCDIP) +6%. Skylight Health Group (SLHG) +6% executes definitive agreement to acquire NeighborMD to expand in Florida and enters medicare advantage global risk. Tarsus Pharmaceuticals (TARS) +6% announces pricing of upsized $75.6 Million underwritten public offering of common stock. Aquestive Therapeutics (AQST) +6%. Tremor International (TRMR) +4%. Nutrien NTR +5% on Q1 results. BP BP +5% on Q1 results. Agora (API) +5%. Grifols (GRFS) +5%.

For further details see:

MFGP, API and AQST among pre market gainers

Company Name:	Harbor Custom Development Inc. 8.0% Series A Cumulative Convertible Preferred Stock no par value
Stock Symbol:	HCDIP
Market:	NASDAQ

Twitter